• Constems AI Systems

  Participated · Series A · Mar 2026

  Founded in 2017, Noida-based Constems AI Systems delivers enterprise-grade vision intelligence that turns retail shelf images and supply-chain video feeds into real-time predictive analytics. Its patented object-detection model and edge architecture draw on more than 30 million curated image data points and 30,000 consumer-product formats to identify products, measure compliance, and optimize sales and inventory. The platform helps Fortune 500 CPG brands boost shelf intelligence, monitor merchandising standards, and improve supply-chain efficiency. Constems claims 2–3× year-on-year growth as enterprise adoption accelerates. Future plans include expanding deployments across Southeast Asia, Japan, and the Middle East, deepening AI model development, and strengthening its global enterprise sales engine. The new capital will also go toward enhancing product and data infrastructure to support international scale.

• Bluebird Kids Health

  Participated · Equity · Mar 2025

  Bluebird Kids Health is a value-based pediatric care practice that combines 24/7 access, pediatricians and care teams, convenient locations, and integrated virtual care. The company is led by CEO and Founder Chris Johnson and is based in Boston, MA. It currently operates three locations and serves roughly 20,000 active patients. Bluebird plans to expand its operations and invest in R&D to scale its care model. The company will apply its model to new, de novo practice locations and has construction already underway in Jacksonville. The recent capital raise is intended to support these expansion and R&D efforts.

• Aphea.Bio

  Participated · Series C · Jul 2023

  Aphea.bio specialises in developing microbial strains and biostimulant products that boost plant nutrient uptake. The company is certified as a B Corp and employs a team of over 50 scientists and specialists. New funding will be used to expand research facilities and to open a new pilot plant later this year. A partnership with the Bill & Melinda Gates Foundation will direct development of products for smallholder farmers in Sub-Saharan Africa and South Asia. Financially, Aphea.bio has raised just over €100 million since mid-2017, with the latest round contributing to that total. The company is based in Gent, Belgium. Aphea.Bio develops a new generation of agro-biologicals—biostimulants and biofungicides—by harnessing the plant microbiome and natural microbial biodiversity. The company uses an innovative discovery platform that combines proprietary technologies to analyze microbial collections and identify beneficial strains. Its products target reduced fertilizer application and control of fungal diseases in row crops such as maize and wheat. With the completion of its Series B to €18M, Aphea.Bio plans to advance its portfolio toward regulatory approval and first commercial launch. ECBF's equity investment will support development and commercialization efforts to substitute agricultural chemicals with biological alternatives. Aphea.Bio was founded in December 2016 as a spin-off of VIB, Ghent University and K.U. Leuven and is based in Gent, Belgium. Aphea.Bio develops next-generation biopesticides and biostimulants based on naturally-occurring microorganisms to increase crop yields and improve protection against fungal diseases. The company aims to provide farmers an alternative to chemical pesticides and to stimulate crop growth by promoting nutrient uptake. Development is focused on staple crops such as wheat, barley and maize to target European and global market opportunities. Aphea.Bio spun out of the Vlaams Instituut voor Biotechnologie (VIB) and draws on research contributions from Ghent University and KU Leuven. Headquartered in Ghent, Belgium, the startup raised €9.0M comprising a €7.7M Series A and a €1.3M R&D grant from VLAIO. Management says the financing positions the company to develop new agricultural products and to exploit the currently untapped microbial space.

• Huy Vietnam

  Participated · Series B · Sep 2014

  Huy Vietnam Group Limited is one of Vietnam’s first international, professionally managed restaurant companies, operating since 2007. The company runs over 70 restaurants under the Mon Hue, Com Express and Pho Ong Hung brands, serving regional Vietnamese cuisines. Its core product is affordable, authentic local Vietnamese food prepared from formulated family recipes in modern, comfortable environments. The Series C proceeds will be used to support network expansion in Ho Chi Minh City, Hanoi and other cities. Huy Vietnam plans additional openings in 2015 and intends to expand to Nha Trang, Hue and Dalat in the second half of 2015. Management emphasizes a multi-brand strategy (central, southern and northern Vietnamese cuisines) to capture market share across regions. Huy Vietnam Group Limited is a Vietnam-based operator of self-managed, local Vietnamese food restaurants. Launched in 2007 by Chairman and CEO KY Huy, the company serves traditional Vietnamese food prepared from formulated family-owned recipes. It currently runs over 40 restaurants under the Mon Hue, Com Express and Pho Ong Hung brands. The company secured US$15.0m in Series B equity financing. The funds are intended for network expansion in Ho Chi Minh City and Hanoi. Backers in the round included New Asia Partners, AIF Capital and Fortress Capital.

• Raven360

  Participated · Series A · Jun 2013

  Raven360 offers Digital Academies that let marketing teams embed knowledge-rich learning environments into their websites so prospects can research, demo and purchase products on their own terms. By aligning seller content with buyer problems from the first interaction, the platform turns web visitors into informed product evaluators and ultimately qualified leads. These academies generate predictive insights into each prospect’s stage in the buying journey, enabling marketing and sales teams to support buyer-led purchases more effectively. Fast-growing companies worldwide use Raven360 to onboard, teach, coach and inspire customers, partners and employees. With its newly raised capital, the company will expand sales and marketing, enhance the user experience and interface, and integrate machine-learning and AI capabilities to deepen engagement. Headquartered in Marlborough, Massachusetts, Raven360 positions itself as a critical tool in the modern CMO’s toolkit for creating top-of-funnel opportunities.

No current team members are available.